These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20514603)

  • 1. Repeated measurements of 11β-HSD-1 activity in subcutaneous adipose tissue from lean, abdominally obese, and type 2 diabetes subjects--no change following a mixed meal.
    Sjöstrand M; Jansson PA; Palming J; de Schoolmeester J; Gill D; Rees A; Sjögren L; Persson T; Eriksson JW
    Horm Metab Res; 2010 Oct; 42(11):798-802. PubMed ID: 20514603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
    Paulsen SK; Pedersen SB; Fisker S; Richelsen B
    Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients.
    Desbriere R; Vuaroqueaux V; Achard V; Boullu-Ciocca S; Labuhn M; Dutour A; Grino M
    Obesity (Silver Spring); 2006 May; 14(5):794-8. PubMed ID: 16855188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11β-hydroxysteroid dehydrogenase types 1 and 2 activity in subcutaneous adipose tissue in humans: implications in obesity and diabetes.
    Dube S; Norby BJ; Pattan V; Carter RE; Basu A; Basu R
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E70-6. PubMed ID: 25303491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the macrophage markers and of 11beta-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity.
    Makkonen J; Westerbacka J; Kolak M; Sutinen J; Cornér A; Hamsten A; Fisher RM; Yki-Järvinen H
    Int J Obes (Lond); 2007 Oct; 31(10):1617-25. PubMed ID: 17452990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss.
    Engeli S; Böhnke J; Feldpausch M; Gorzelniak K; Heintze U; Janke J; Luft FC; Sharma AM
    Obes Res; 2004 Jan; 12(1):9-17. PubMed ID: 14742837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone decreases 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue.
    Mai K; Andres J; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):419-25. PubMed ID: 17555498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human adipose tissue under in vitro inhibition of 11beta-hydroxysteroid dehydrogenase type 1: differentiation and metabolism changes.
    Bader T; Zoumakis E; Friedberg M; Hiroi N; Chrousos GP; Hochberg Z
    Horm Metab Res; 2002; 34(11-12):752-7. PubMed ID: 12660894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
    Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
    Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
    J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.
    Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR
    J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.
    Valsamakis G; Anwar A; Tomlinson JW; Shackleton CH; McTernan PG; Chetty R; Wood PJ; Banerjee AK; Holder G; Barnett AH; Stewart PM; Kumar S
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4755-61. PubMed ID: 15356090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.
    Dube S; Norby B; Pattan V; Lingineni RK; Singh RJ; Carter RE; Basu A; Basu R
    Diabetologia; 2014 Jul; 57(7):1446-55. PubMed ID: 24771091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11Beta hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle.
    Jang C; Obeyesekere VR; Dilley RJ; Alford FP; Inder WJ
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):800-5. PubMed ID: 17121533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.